Outcomes and cause of death of patients admitted with or developing LGIB while an established inpatient
| Acute admissions N=2331 N (%) | Inpatients N=185 N (%) | All patients Total N=2528 N (%) | |
|---|---|---|---|
| In-hospital mortality | |||
| All | 51 (2.2) | 33 (17.8) | 85 (3.4) |
| Due to LGIB* | 3 (0.1) | 1 (0.5) | 4 (0.2) |
| (Missing) | 34 | 1 | 36 |
| Primary cause of death† | |||
| GI malignancy | 7 | 3 | 10 |
| Non-GI malignancy | 2 | 2 | 4 |
| Intra-abdominal sepsis | 10 | 7 | 17 |
| Pneumonia | 4 | 3 | 7 |
| Myocardial infarction and heart failure | 4 | 3 | 7 |
| Stroke | 0 | 2 | 2 |
| Frailty | 0 | 1 | 1 |
| Other‡ | 4 | 1 | 5 |
| Unknown§ | 17 | 10 | 28 |
| Rebleeding¶ | 293 (12.6) | 49 (26.5) | 343 (13.6) |
| (Missing) | 113 | 12 | 126 |
| Median length of stay (IQR) | 3 (1–6) | 9 (5–21) | 3 (1–7) |
| (Missing) | 115 | 39 | 156 |
| Readmission within 28 days | |||
| All | 244 (10.5) | 16 (8.6) | 260 (10.3) |
| Due to further LGIB | 107 (4.6) | 4 (2.2) | 111 (4.4) |
| Unknown | 505 | 26 | 535 |
All patients include 12 cases where mode of presentation was unclassified.
*The four patients who died from haemorrhage also had significant comorbidities; two had metastatic colorectal cancers and two had severe aortic stenosis. The latter two did not have a source of LGIB localised.
†As documented on the primary cause of death on the death certificate.
‡Other: decompensated liver disease, infective endocarditis, status epilepticus, chronic obstructive pulmonary disease, dementia.
§Unknown: death certificate not available.
¶Rebleeding defined as additional blood transfusion requirements and/or a further decrease in haematocrit ≥20% after 24 hours of clinical stability.18
LGIB, lower GI bleeding.